Answers are grounded in this paper and cite their sources.
These data are important in providing evidence that SSc bowel disease affects transit of GI content and that delay in transit accounts in part for both bowel symptoms and Medsger GI severity. Prospective studies examining the benefit of early therapeutic intervention targeting GI transit abnormalities in patients at high risk for severe GI complications are needed.
No takes yet. Share an insight, caveat, or question.
McMahan et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: